Why this broker sees the Coles (ASX:COL) share price rising 15%

Now could be a good time to buy Coles shares according to one leading broker…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Coles Group Ltd (ASX: COL) share price is pushing higher on Thursday afternoon.

At the time of writing, the supermarket giant's shares are up almost 1% to $17.15.

This means Coles' shares have now reduced their year to date decline to approximately 7%.

A young boy pushing his friend in a shopping trolley race along the road.

Image source: Getty Images

Is the Coles share price good value?

While the weakness in the Coles share price this year is disappointing for shareholders, it could be a buying opportunity for non-shareholders.

According to a recent note out of Morgans, its analysts have an add rating and $19.80 price target on the company's shares.

Based on the current Coles share price, this suggests there is 15% upside over the next 12 months before dividends.

And if we include dividends, the potential return gets even more attractive. Morgans is forecasting a fully franked 61 cents per share dividend in FY 2022. Including this, the company's shares could provide a total return of 19% between now and this time next year.

What did the broker say?

Morgans was pleased with the company's performance in FY 2021 and also with its solid start to the new financial year. This led the broker to upgrading its forecasts for FY 2022 and its price target on the Coles share price accordingly.

In addition to this, its analysts like Coles due to its defensive qualities, strong market position, and robust balance sheet.

The broker commented: "Following the better-than-expected FY21 result, we increase FY22F EBIT by 2% to A$1,852m while underlying NPAT rises by 4% to A$996m. COL is a defensive business with strong market positions and a healthy balance sheet. Trading on 24.6x FY22F PE and 3.3% yield we continue to see the stock as offering good value and maintain our Add rating."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COLESGROUP DEF SET. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »